metricas
covid
Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Cystic Hepatic Lymphangioma: A Rare Cause of Abdominal Pain in the Adult
Journal Information
Vol. 91. Issue 2.
Pages e11 (February 2013)
Vol. 91. Issue 2.
Pages e11 (February 2013)
Image of the Month
Full text access
Cystic Hepatic Lymphangioma: A Rare Cause of Abdominal Pain in the Adult
Linfangioma quístico hepático: una causa excepcional de dolor abdominal en el adulto
Visits
2902
Emilio Peña Ros
Corresponding author
emilio.doctor@gmail.com

Corresponding author.
, Mari Fe Candel Aremas, Patricia Pastor Pérez, Antonio Albarracín Marín-Blázquez
Servicio de Cirugía General y del Aparato Digestivo, Hospital General Universitario Reina Sofía, Murcia, Spain
This item has received
Article information
Full Text
Download PDF
Statistics
Figures (2)
Full Text

A 20-year-old woman came to our Emergency Department due to abdominal pain and distension. On physical examination, a palpable abdominal mass was noticed on the right upper quadrant, with voluntary guarding and no peritoneal irritation. Abdominal X-ray showed displacement of the colon by a mass in the right hemi-abdomen (Fig. 1). Abdominal CT (Fig. 2) revealed a hepatic cyst measuring 13.3cm×9.3cm×9.7cm in the right hepatic lobe (segment V) causing caudal displacement of the right kidney, with a limited amount of free fluid in the cavity. The patient was operated on and a large hepatic cystic tumor (15cm×9cm) was resected. The pathology report defined the tumor as a cystic hepatic lymphangioma.

Fig. 1
(0.06MB).
Fig. 2
(0.06MB).

Please cite this article as: Peña Ros E, et al. Linfangioma quístico hepático: una causa excepcional de dolor abdominal en el adulto. Cir Esp. 2013;91:e11.

Copyright © 2011. AEC
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos